Thyrocare Technologies Limited THYROCARE

Latest filings

• Management change38 6 Nov, 16:56 · NSE
  Resignation of Director/KMP/SMP
• Routine15 6 Nov, 16:44 · NSE
  Allotment of 194289 Equity Shares pursuant to the Thyrocare Employee Stock Option Scheme.
• Routine15 6 Nov, 16:34 · BSE
  Please find the enclosed announcement.
• Management change73 6 Nov, 16:31 · NSE
  Resignation of Dr. Preet Kaur as Chief Scientific Officer of the company w.e.f. November 06, 2026.
• Routine15 2 Nov, 12:57 · NSE
  Transcript
• Routine15 2 Nov, 12:54 · BSE
  Please find attached the Earnings Call Transcript held on October 29, 2026
• General25 30 Oct, 17:32 · NSE
  Execution of Share Purchase Agreement in relation to the sale of the Company s entire shareholding in Nueclear Healthcare Limited, a wholly owned subsidiary of the Company.
• Board meeting45 30 Oct, 17:28 · BSE
  Please find attached Intimation regarding the Execution of Share Purchase Agreement
• Routine15 30 Oct, 11:42 · BSE
  Please find attached herewith Newspaper Publication of Unaudited Financial Results for the quarter and half year ended on September 30, 2026
• Routine15 29 Oct, 22:03 · BSE
  Please find attached herewith the Scrutinizers Report of Postal Ballot and Voting Results

Shown 15 minutes after publication. Real time with Pro.